Evidence map›Paper›PMID 39080231›Full record

ReviewJournal of community genetics2024

Is Tunisia ready for precision medicine? Challenges of medical genomics within a LMIC healthcare system.

Narjes Trabelsi, Houcemeddine Othman, Hafsi Bedhioufi, Hamza Chouk, Haïfa El Mabrouk, Marwa Mahdouani, Moez Gribaa, Ali Saad, Dorra H'mida

Abstract readReview
In one paragraph

Review in Journal of community genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Narjes Trabelsi *Department of genetics, Farhat Hached University Hospital, Ibn El Jazzar St, Sousse, 4000, Tunisia.
Houcemeddine Othman *Department of genetics, Farhat Hached University Hospital, Ibn El Jazzar St, Sousse, 4000, Tunisia.
Hafsi BedhioufiInterdisciplinary Laboratory of University-Business Management (LIGUE), (LR99ES24), Higher Institute of Accounting and Business Administration (ISCAE), University of La Manouba, Manouba university campus, La Manouba, 2010, Tunisia.
Hamza ChoukLaboratory of cytogenetics, molecular genetics and reproductive biology (LR03SP02), Farhat Hached University Hospital, Ibn El Jazzar St, Sousse, 4000, Tunisia.
Haïfa El MabroukLaboratory of cytogenetics, molecular genetics and reproductive biology (LR03SP02), Farhat Hached University Hospital, Ibn El Jazzar St, Sousse, 4000, Tunisia.
Marwa MahdouaniLaboratory of cytogenetics, molecular genetics and reproductive biology (LR03SP02), Farhat Hached University Hospital, Ibn El Jazzar St, Sousse, 4000, Tunisia.
Moez GribaaDepartment of genetics, Farhat Hached University Hospital, Ibn El Jazzar St, Sousse, 4000, Tunisia.
Ali SaadDepartment of genetics, Farhat Hached University Hospital, Ibn El Jazzar St, Sousse, 4000, Tunisia.
Dorra H'midaDepartment of genetics, Farhat Hached University Hospital, Ibn El Jazzar St, Sousse, 4000, Tunisia. dorrahmida@yahoo.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As one of the key tools on the precision medicine workbench, high-throughput genetic testing has enormous promise for improving healthcare outcomes. Tunisia has made tremendous progress in acquiring and implementing the technology in the clinical context. However, current utilization does not ensure the whole range of benefits that high-throughput genomic testing provides which impedes the country's ability to move forward into the new era of precision medicine. This issue is primarily related to the current state of Tunisia's healthcare ecosystem and the sociological attributes of its population, creating numerous challenges that must be addressed. In the current review, we aimed to identify and highlight these challenges that may be prevalent in other low and middle-income countries. Essentially, they fall into three main categories that include the socio-economic landscape in Tunisia, which prevents citizens from engaging in precision medicine activities; the current settings of the healthcare system that lack or miss key components for the successful implementation of precision medicine practices; and the inability of the current infrastructure and resources to handle the various challenges related to genomic data and metadata. We also propose five pillar solutions as a framework for addressing all of these challenges, which could strengthen Tunisia's capability for effective precision medicine implementation in today's clinical environment.

Indexed as

Genomic testingHigh-throughput genetic analysisLow and middle-income countriesNext generation sequencingPrecision medicine

Identifiers

PMID39080231
PMCPMC11411033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.